226 results
DEFA14A
REGN
Regeneron Pharmaceuticals, Inc.
25 Apr 24
Additional proxy soliciting materials
4:02pm
requesting simple majority voting requirements, if properly presented.
Against
NOTE: Such other business as may properly come before the meeting or any
8-K
EX-99.1
8bp3b5 3h
8 Jan 24
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
6:30am
8-K
EX-99.1
4gnll jhu0zz9v
2 Nov 23
Regeneron Reports Third Quarter 2023 Financial and Operating Results
7:10am
8-K/A
lojlgo k2lh97x8t1mg
8 Sep 23
Submission of Matters to a Vote of Security Holders
5:00pm
SC TO-T
EX-99
9nwkoxf4h
25 Aug 23
Third party tender offer statement
7:46am
SC TO-T
EX-99
r1l4 b6e5b8
25 Aug 23
Third party tender offer statement
7:46am
SC TO-C
EX-99.1
ipntcp8b
9 Aug 23
Information about tender offer
4:15pm
8-K
EX-99.1
qwqyo6
3 Aug 23
Regeneron Reports Second Quarter 2023 Financial and Operating Results
6:48am
8-K
sqt fh9toh
14 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:07pm
DEFA14A
yrcpve0xujtm9vnzmz
17 May 23
Additional proxy soliciting materials
4:04pm
8-K
EX-10.1
xzi32g73cyh9g9 cmua
29 Mar 23
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
amc03kuoeggb b1sf6
20 Dec 22
Entry into a Material Definitive Agreement
4:01pm